Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

H. Lee Moffitt Cancer Center and Research Institute · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
melanoma (skin), stage iv melanoma, stage iiic melanoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 904279
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.